The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects
Abstract
SUMMARY: Background: Advanced glycation end products (AGEs) evoke oxidative stress generation and inflammatory reactions, thus being involved in vascular complications in diabetes. Since oxidative stress and inflammation impair insulin actions as well, it is conceivable that AGEs may play some role in insulin resistance. However, there is no clinical study to examine the relationship between serum levels of AGEs and insulin resistance. This study investigated whether serum AGE levels were independent correlates of insulin resistance in humans. Methods: Three hundred twenty‐two nondiabetic Japanese subjects (216 male and 106 female; mean age 61.5 ± 9.1 years) underwent a complete history and physical examination, determinations of blood chemistries, anthropometric and metabolic variables, including AGEs. Serum AGE levels were examined with an enzyme‐linked immunosorbent assay. Results: Mean serum AGE levels were 8.96 ± 2.57 U/mL. In univariate analysis, waist circumference, diastolic blood pressure (BP), mean BP, AGEs, low‐density lipoprotein (LDL) cholesterol, triglycerides, high‐density lipoprotein (HDL) cholesterol (inversely), hemoglobin A1c (GHb), creatinine clearance, uric acid, and high sensitivity C‐reactive protein were significantly associated with insulin resistance evaluated by homeostasis model assessment of insulin resistance (HOMA‐IR) index. After performing multiple regression analysis, waist circumference (P < 0.001), GHb (P < 0.001), triglycerides (P < 0.001), and AGEs (P < 0.01) still remained significant independently. When age‐adjusted HOMA‐IR levels stratified by AGE tertiles were compared using ANCOVA, a significant trend was demonstrated in both males and females. Conclusion: The present study demonstrated for the first time that serum AGE levels were one of the independent correlates of HOMA‐IR index, thus suggesting that AGEs may play some pathological role in insulin resistance in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and correlate with HOMA-IR in nondiabetic subjects.[112]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [112]
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Vlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 848
Activation of Receptor for Advanced Glycation End Products
Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 799
Renal Insufficiency and Heart Failure
McAlister, F. A., Ezekowitz, J. A., Tonelli, M. A., & Armstrong, P. W. (2004) · Circulation · doi:10.1161/01.cir.0000116764.53225.a9 · Cited by 702
Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., & Vlassara, H. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.427 · Cited by 570
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
Grandhee, S. K., & Monnier, V. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99006-x · Cited by 459
Yamagishi, S., & Imaizumi, T. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054367300 · Cited by 455
Self-citationNonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
Pοlyzos, S. A., Kountouras, J., & Zavos, C. (2009) · Current Molecular Medicine · doi:10.2174/156652409787847191 · Cited by 333
Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes
Tan, K. C. B., Chow, W.-S., Ai, V. H. G., Metz, C. N., Bucala, R., & Lam, K. S. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1055 · Cited by 318
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Wei, Y., Chen, K., Whaley‐Connell, A. T., Stump, C. S., Ibdah, J. A., & Sowers, J. R. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00561.2007 · Cited by 270
Kilhovd, B. K., Berg, T. J., Birkeland, K. I., Thorsby, P. M., & Hanssen, K. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1543 · Cited by 269
Takeuchi, M., & Yamagishi, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784139693 · Cited by 220
Self-citationHyogo, H., Yamagishi, S., Iwamoto, K., Arihiro, K., Takeuchi, M., Sato, T., Ochi, H., Nonaka, M., Nabeshima, Y., Inoue, M., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04943.x · Cited by 188
Self-citationTAGE (Toxic AGEs) Theory in Diabetic Complications
Sato, T., Iwaki, M., Shimogaito, N., Wu, X., Yamagishi, S., & Takeuchi, M. (2006) · Current Molecular Medicine · doi:10.2174/156652406776894536 · Cited by 183
Self-citationElevated Serum Levels of Pigment Epithelium-Derived Factor in the Metabolic Syndrome
Yamagishi, S., Adachi, H., Abe, A., Yashiro, T., Enomoto, M., Furuki, K., Hino, A., Jinnouchi, Y., Takenaka, K., Matsui, T., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2654 · Cited by 181
Self-citationLamb, R. E., & Goldstein, B. J. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01789.x · Cited by 168
Atherosclerosis and diabetes: The rage connection
Schmidt, A. M., & Stern, D. M. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0082-4 · Cited by 167
Kilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Hanssen, K. F., & Laakso, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0687-z · Cited by 167
Miura, J., Yamagishi, S., Uchigata, Y., Takeuchi, M., Yamamoto, H., Makita, Z., & Iwamoto, Y. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00183-6 · Cited by 157
Self-citationUnoki‐Kubota, H., Bujo, H., Yamagishi, S., Takeuchi, M., Imaizumi, T., & Saitō, Y. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.016 · Cited by 155
Self-citationMiele, C., Riboulet, A., Maitan, M. A., Oriente, F., Romano, C., Formisano, P., Giudicelli, J., Bèguinot, F., & OBBERGHEN, E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301088200 · Cited by 141
Takeuchi, M., & Yamagishi, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0974 · Cited by 122
Self-citationKilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Birkeland, K. I., Berg, T. J., Hanssen, K. F., & Laakso, M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000158380.44231.fe · Cited by 122
Yamagishi, S., Ueda, S., & Okuda, S. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781757051 · Cited by 119
Self-citationAssociation Between Acute-Phase Reactants and Advanced Glycation End Products in Type 2 Diabetes
Tan, K. C. B., Chow, W.-S., Tam, S., Bucala, R., & Betteridge, J. D. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.223 · Cited by 117
Inflammation and the metabolic syndrome: Role of angiotensin II and oxidative stress
Ferder, L., Inserra, F., & Martínez–Maldonado, M. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0050-7 · Cited by 97
Nakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.09.004 · Cited by 96
Self-citationNakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.766 · Cited by 86
Self-citationMeerwaldt, R., Zeebregts, C. J., Navis, G. J., Hillebrands, J., Lefrandt, J. D., & Smit, A. J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.031 · Cited by 69
Yamagishi, S., Nakamura, K., & Matsui, T. (2007) · Current Molecular Medicine · doi:10.2174/156652407781387073 · Cited by 62
Self-citationMuellenbach, E. A., Diehl, C. J., Teachey, M. K., Lindborg, K. A., Archuleta, T. L., Harrell, N. B., Andersen, G., Somoza, V., Hasselwander, O., Matuschek, M., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.018 · Cited by 58
Yoshida, T., Yamagishi, S., Nakamura, K., Matsui, T., Imaizumi, T., Takeuchi, M., Koga, H., Ueno, T., & Sata, M. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1083785 · Cited by 47
Self-citationEnomoto, M., Adachi, H., Yamagishi, S., Takeuchi, M., Furuki, K., Hino, A., Hiratsuka, A., Takajo, Y., & Imaizumi, T. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.019 · Cited by 44
Self-citationKey role of insulin resistance in vascular injury among hemodialysis patients
Takenaka, T., Kanno, Y., Ohno, Y., & Suzuki, H. (2007) · Metabolism · doi:10.1016/j.metabol.2006.08.010 · Cited by 39
Yamagishi, S., Adachi, H., Takeuchi, M., Enomoto, M., Furuki, K., Matsui, T., Nakamura, K., & Imaizumi, T. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-991176 · Cited by 36
Self-citation
Cited by
Sorted by citations
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095
“Insulin resistance was estimated by the homeostatic model assessment index (HOMA-IR) which is based on the calculation of fasting insulin and glucose concentration [76].”
BackgroundAdvanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart
Abel, E. D., O’Shea, K. M., & Ramasamy, R. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241984 · Cited by 253
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction
Sergi, D., Boulestin, H., Campbell, F. M., & Williams, L. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900934 · Cited by 194
Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease
Ruiz, H. H., Ramasamy, R., & Schmidt, A. M. (2019) · Endocrinology · doi:10.1210/endocr/bqz006 · Cited by 186
Metadata
- Authors
- Tahara, N., Yamagishi, S., Matsui, T., Takeuchi, M., Nitta, Y., Kodama, N., Mizoguchi, M., & Imaizumi, T.
- Affiliations
- Kurume University (JP)
- Hokuriku University (JP)
- Corresponding author
- Tahara, Nobuhiro
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2012-01-26
- Volume
- 30
- Issue
- 1
- Pages
- 42-48
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- OpenAlex
- W1509582521
- Cited by
- 116
- References
- 37
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 8 · 2022: 5 · 2021: 10 · 2020: 14 · 2019: 7 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 18 · 2014: 5 · 2013: 11 · 2012: 6
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23591072, 22300264)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- advanced glycation end products, insulin resistance, non-diabetic adults, HOMA-IR, waist circumference, HbA1c, triglycerides, oxidative stress, inflammation, C-reactive protein, uric acid, LDL cholesterol, HDL cholesterol, diastolic blood pressure, creatinine clearance
- MeSH terms
- Aged, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Humans, Insulin Resistance, Japan, Male, Middle Aged, Regression Analysis, Risk Factors, Biomarkers, Multivariate Analysis, Glycation End Products, Advanced, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review